Fig. 7From: Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trialCorrelation between the injection radioactivity and each peak area. (a) The peak area of mass spectrum (m/z = 210.988046 ± 10 ppm). (b) The peak area of [211At]NaAt radioactivityBack to article page